COVID-19: Vaccines and therapeutics

Bioorg Med Chem Lett. 2022 Nov 1:75:128987. doi: 10.1016/j.bmcl.2022.128987. Epub 2022 Sep 14.

Abstract

Coronavirus disease 2019 (COVID-19) is a communicable disease triggered by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged as leading cause of death from a single infectious agent globally. Despite of rigorous protective measures, availability of multiple vaccines and with few approved therapeutics, the virus effect on the humankind throughout the world is perennial. COVID-19 has become the most urgent health concern with emergence of new challenging variants which outnumbered all other health issues and ensued in overwhelming number of reported deaths. In this unprecedented period of COVID-19 pandemic, scientists work round the clock for rapid development of efficient vaccines for prevention of infection and effective therapeutics for treatment. Here, we report the status of COVID-19 and highlight the ongoing research and development of vaccines and therapeutic strategies. It is necessary to know the present situation and available options to fight against the COVID-19 pandemic.

Keywords: COVID-19; COVID-19 therapeutics; COVID-19 vaccines; New variants of SARS-CoV-2; SARS-CoV-2.

Publication types

  • Review

MeSH terms

  • COVID-19* / therapy
  • Humans
  • Pandemics / prevention & control
  • SARS-CoV-2
  • Vaccines*

Substances

  • Vaccines